Yield10 Bioscience, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 3.27 million compared to USD 3.3 million a year ago. Basic loss per share from continuing operations was USD 6.48 compared to USD 16.08 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.11 USD | -10.97% | -65.07% | -63.26% |
May. 15 | Earnings Flash (YTEN) YIELD10 BIOSCIENCE Posts Q1 Revenue $300,000 | MT |
May. 15 | Top Midday Decliners | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-63.26% | 1.36M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- YTEN Stock
- News Yield10 Bioscience, Inc.
- Yield10 Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023